Real-time in vivo monitoring of the antimicrobial action of combination therapies in the management of infected topical wounds

Landa, Guillermo (Universidad de Zaragoza) ; Miranda-Calderón, Laura G. (Universidad de Zaragoza) ; Gómez, Alex (Universidad de Zaragoza) ; Pérez, Marta (Universidad de Zaragoza) ; Sebastian, Víctor (Universidad de Zaragoza) ; Arruebo, Manuel (Universidad de Zaragoza) ; Lamarche, Isabelle ; Tewes, Frederic ; Irusta, Silvia (Universidad de Zaragoza) ; Mendoza, Gracia

Resumen: The increasing prevalence of non-healing infected wounds has become a serious concern in the clinical practice, being associated to population aging and to the rising prevalence of several chronic conditions such as diabetes. Herein, the evaluation of the bactericidal and antibiofilm effects of the natural antiseptic terpenes thymol and farnesol standing alone or in combination with the standard care antiseptic chlorhexidine was carried out both in vitro and in vivo. The in vitro combinatorial treatment of chlorhexidine associated with those terpenes against Staphylococcus aureus in its planktonic and sessile forms demonstrated a superior antibacterial activity than that of chlorhexidine alone. Real-time in vivo monitoring of infection progression and antimicrobial treatment outcomes were evaluated using the bioluminescent S. aureus strain Xen36. In vivo studies on infected wound splinting murine models corroborated the superior bactericidal effects of the combinatorial treatments here proposed. Moreover, the encapsulation of thymol in electrospun Eudragit® S100 (i.e., a synthetic anionic copolymer of methacrylic acid and ethyl acrylate)-based wound dressings was also carried out in order to design efficient antimicrobial wound dressings.

Idioma: Inglés

DOI: 10.1016/j.ijpharm.2023.123502

Año: 2023

Publicado en: International Journal of Pharmaceutics 646 (2023), 123502 [10 pp.]
ISSN: 0378-5173

Factor impacto JCR: 5.3 (2023)

Categ. JCR: PHARMACOLOGY & PHARMACY rank: 35 / 354 = 0.099 (2023) - Q1 - T1

Factor impacto CITESCORE: 10.7 - Pharmaceutical Science (Q1)

Factor impacto SCIMAGO: 0.954 - Pharmaceutical Science (Q1)

Financiación: info:eu-repo/grantAgreement/ES/ISCIII/MS19-00092
Financiación: info:eu-repo/grantAgreement/ES/MCINN/PRE2018-085769
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PDC2021-121405-I00
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PID2020-113987RB-I00

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Sanidad Animal (Dpto. Patología Animal)
Área (Departamento): Área Anatom.Anatom.Patológ.Com (Dpto. Anatom.,Embri.Genét.Ani.)
Área (Departamento): Área Ingeniería Química (Dpto. Ing.Quím.Tecnol.Med.Amb.)
Área (Departamento): Área Tecnologi. Medio Ambiente (Dpto. Ing.Quím.Tecnol.Med.Amb.)